Professor and Chair ad interim
McGovern Medical School at UT Health, Houston Texas
Houston, Texas, United States
Nitin Tandon MD, FAANS, FACNS, FAES is Professor and Chairman ad interim,Department of Neurosurgery, UT Health, Houston, Texas
Co-director of the Texas Institute of Restorative Neurotechnologies, Chief of the Neurosurgery at Memorial Hermann Hospital in the Texas Medical Center and director of the Epilepsy Surgery Program at the Texas Comprehensive Epilepsy Program.
Dr Tandon’s practice includes the surgical treatment of epilepsy, brain tumors, trigeminal neuralgia, radiosurgery and general neurosurgery. He has pioneered innovative technologies including robotic stereo-electroencephalography, laser interstitial ablation and other minimally invasive approaches to brain tumors and epilepsy. He has a particular interest in functional mapping and preservation during cortical resections. His research work is aligned with his clinical practice and is focused on the study of language and epilepsy via intracranial recordings and cortical stimulation. He has been the recipient of multiple NIH and NSF grants over the years and was awarded a STARS award by the State of Texas in 2019. He has authored over 125 peer reviewed publications
Update in STN and Gpi Targeting for Deep Brain Stimulation
Friday, April 21, 2023
11:47am – 12:02pm PST
Disclosure(s): BrainDynamics: Ownership Interest (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Nervonik: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Friday, April 21, 2023
12:02pm – 12:17pm PST
Disclosure(s): BrainDynamics: Ownership Interest (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Nervonik: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Connectomic Analysis of Deep Brain Stimulation Effects
Friday, April 21, 2023
12:17pm – 12:32pm PST
Disclosure(s): BrainDynamics: Ownership Interest (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Nervonik: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)
Discussion - Stereotactic & Functional
Friday, April 21, 2023
12:32pm – 12:36pm PST
Disclosure(s): BrainDynamics: Ownership Interest (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Nervonik: Advisor (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing)